Stayble Therapeutics files for bankruptcy
Stayble Therapeutics has announced that its Board of Directors has resolved to file for bankruptcy, with the application to be submitted to the Gothenburg District Court.
The decision follows the company’s earlier announcement on May 6 of a non-binding letter of intent regarding short- and long-term financing to support continued operations. According to Stayble, subsequent work revealed information that made short-term financing unattainable. In addition, the Board cited structural and regulatory challenges in the proposed transaction that could not be resolved within a reasonable timeframe.
Given the company’s strained liquidity position, the Board concluded that available financing is insufficient to meet outstanding obligations or sustain operations.
Published: June 3, 2026
